These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26108990)

  • 1. Association between all-cause and cause-specific mortality and the GOLD stages 1-4: A 30-year follow-up among Finnish adults.
    Mattila T; Vasankari T; Kanervisto M; Laitinen T; Impivaara O; Rissanen H; Knekt P; Jousilahti P; Saarelainen S; Puukka P; Heliövaara M
    Respir Med; 2015 Aug; 109(8):1012-8. PubMed ID: 26108990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.
    Mannino DM; Diaz-Guzman E
    Chest; 2012 Jan; 141(1):73-80. PubMed ID: 21659434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can global initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men?
    Stavem K; Sandvik L; Erikssen J
    Chest; 2006 Aug; 130(2):318-25. PubMed ID: 16899828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung function decline and outcomes in an elderly population.
    Mannino DM; Davis KJ
    Thorax; 2006 Jun; 61(6):472-7. PubMed ID: 16517577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.
    Ekberg-Aronsson M; Pehrsson K; Nilsson JA; Nilsson PM; Löfdahl CG
    Respir Res; 2005 Aug; 6(1):98. PubMed ID: 16120227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization.
    Johannessen A; Nilsen RM; Storebø M; Gulsvik A; Eagan T; Bakke P
    Am J Respir Crit Care Med; 2013 Jul; 188(1):51-9. PubMed ID: 23590268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible airway obstruction in adulthood after bronchiolitis in infancy: evidence from a 30-year follow-up study.
    Backman K; Piippo-Savolainen E; Ollikainen H; Koskela H; Korppi M
    Respir Med; 2014 Jan; 108(1):218-23. PubMed ID: 24345311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA.
    Ohrlander T; Dencker M; Acosta S
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):43-7. PubMed ID: 22051733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.
    Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW
    Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function decline and outcomes in an adult population.
    Mannino DM; Reichert MM; Davis KJ
    Am J Respir Crit Care Med; 2006 May; 173(9):985-90. PubMed ID: 16439715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.
    Soriano JB; Lamprecht B; Ramírez AS; Martinez-Camblor P; Kaiser B; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Marin JM; Puhan MA; Sobradillo P; Lange P; Sternberg AL; Garcia-Aymerich J; Turner AM; Han MK; Langhammer A; Leivseth L; Bakke P; Johannessen A; Roche N; Sin DD
    Lancet Respir Med; 2015 Jun; 3(6):443-50. PubMed ID: 25995071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.
    Mannino DM; Davis KJ; Kiri VA
    Respir Med; 2009 Feb; 103(2):224-9. PubMed ID: 18945605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in all-cause and cardiovascular disease mortality in three different Finnish population cohorts with and without diabetes.
    Barengo NC; Antikainen R; Peltonen M; Tuomilehto J
    Int J Cardiol; 2013 Oct; 168(5):4734-8. PubMed ID: 23962774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.
    Maekura R; Hiraga T; Miki K; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Mori M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1787-800. PubMed ID: 26366071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
    Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.
    Leivseth L; Brumpton BM; Nilsen TI; Mai XM; Johnsen R; Langhammer A
    Thorax; 2013 Oct; 68(10):914-21. PubMed ID: 23611880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial.
    Dusser D; Wise RA; Dahl R; Anzueto A; Carter K; Fowler A; Calverley PM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():133-45. PubMed ID: 26855568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD.
    Budweiser S; Harlacher M; Pfeifer M; Jörres RA
    COPD; 2014 Aug; 11(4):388-400. PubMed ID: 24111878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.